Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

EPICOR Asia-China Extension. Long-term Follow-up of antithrombotIc Management Patterns in Acute Coronary Syndrome Patients in Asia-China Extension

NCT02305680 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT02305680
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02305680 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
EPICOR Asia-China Extension. Long-term Follow-up of antithrombotIc Management Patterns in Acute Coronary Syndrome Patients in Asia-China Extension
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
December 17, 2014
Completion date
April 5, 2017
Enrollment
2,334 (actual)
Sites
33

Conditions

As the registry lists them; a condition with its own page is linked.

acute coronary syndromes